New dual kinase inhibitor MTX-531 shows promise in overcoming cancer therapy resistance

  • Post author:
  • Post category:uncategorized

A team of researchers at the University of Michigan Health Rogel Cancer Center has designed a molecule that impairs signaling mediated by two key drivers of cancer therapy resistance.